Follow
Basel T. Assaf
Basel T. Assaf
Verified email at sanofi.com
Title
Cited by
Cited by
Year
Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis
S Camelo, AH Iglesias, D Hwang, B Due, H Ryu, K Smith, SG Gray, ...
Journal of neuroimmunology 164 (1-2), 10-21, 2005
3242005
Vaccine-induced control of viral shedding following rhesus cytomegalovirus challenge in rhesus macaques
K Abel, J Martinez, Y Yue, SF Lacey, Z Wang, L Strelow, A Dasgupta, Z Li, ...
Journal of virology 85 (6), 2878-2890, 2011
582011
Limited dissemination and shedding of the UL128 complex-intact, UL/b′-defective rhesus cytomegalovirus strain 180.92
BT Assaf, KG Mansfield, L Strelow, SV Westmoreland, PA Barry, A Kaur
Journal of virology 88 (16), 9310-9320, 2014
282014
In vivo overexpression of frataxin causes toxicity mediated by iron-sulfur cluster deficiency
C Huichalaf, TL Perfitt, A Kuperman, R Gooch, RC Kovi, KA Brenneman, ...
Molecular Therapy-Methods & Clinical Development 24, 367-378, 2022
252022
Considerations for preclinical safety assessment of adeno-associated virus gene therapy products
BT Assaf, LO Whiteley
Toxicologic Pathology 46 (8), 1020-1027, 2018
242018
Patterns of acute rhesus cytomegalovirus (RhCMV) infection predict long-term RhCMV infection
BT Assaf, KG Mansfield, SV Westmoreland, A Kaur, KL Oxford, ...
Journal of virology 86 (11), 6354-6357, 2012
232012
Pleural Endometriosis in an Aged Rhesus Macaque (Macaca mulatta) A Histopathologic and Immunohistochemical Study
BT Assaf, AD Miller
Veterinary pathology 49 (4), 636-641, 2012
212012
Live-attenuated lentivirus immunization modulates innate immunity and inflammation while protecting rhesus macaques from vaginal simian immunodeficiency virus challenge
M Genesca, ZM Ma, Y Wang, B Assaf, H Qureshi, L Fritts, Y Huang, ...
Journal of virology 86 (17), 9188-9200, 2012
182012
Scientific and Regulatory Policy Committee points to consider: nonclinical research and development of in vivo gene therapy products, emphasizing adeno-associated virus vectors
JA Hutt, BT Assaf, B Bolon, J Cavagnaro, E Galbreath, B Grubor, ...
Toxicologic Pathology 50 (1), 118-146, 2022
152022
Preclinical biosafety evaluation of cell-based therapies: emerging global paradigms
J Basu, BT Assaf, TA Bertram, M Rao
Toxicologic Pathology 43 (1), 115-125, 2015
152015
Meeting report: spontaneous lesions and diseases in wild, captive-bred, and zoo-housed nonhuman primates and in nonhuman primate species used in drug safety studies
VG Sasseville, KG Mansfield, JL Mankowski, C Tremblay, KA Terio, ...
Veterinary pathology 49 (6), 1057-1069, 2012
152012
Rhesus Cytomegalovirus (Macacine Herpesvirus 3)–Associated Facial Neuritis in Simian Immunodeficiency Virus–Infected Rhesus Macaques (Macaca mulatta)
BT Assaf, HL Knight, AD Miller
Veterinary pathology 52 (1), 217-223, 2015
122015
Growth-associated protein-43 and ephrin B3 induction in the brain of adult SIV-infected rhesus macaques
SV Westmoreland, L Annamalai, MR Lentz, EM Ratai, B Assaf, K Boisvert, ...
Journal of neurovirology 17, 455-468, 2011
62011
Scientific and Regulatory Policy Committee points to consider: sampling, processing, evaluation, interpretation, and reporting of test article-related ganglion pathology for …
BM Bennet, ID Pardo, BT Assaf, E Buza, S Cramer, LTK Crawford, ...
Toxicologic Pathology 51 (4), 176-204, 2023
42023
Cytomegaloviral hypophysitis in a simian immunodeficiency virus‐infected rhesus macaque (Macacca mulatta)
MR Berg, MA Owston, MC Gauduin, BT Assaf, AD Lewis, EJ Dick Jr
Journal of medical primatology 46 (6), 364-367, 2017
42017
Preclinical Study Design for Evaluation of Stem Cell–derived Cellular Therapy Products: A Pathologist’s Perspective
JFM Baker, BT Assaf
Toxicologic Pathology 43 (1), 126-131, 2015
42015
Scientific and Regulatory Policy Committee technical review: biology and pathology of ganglia in animal species used for nonclinical safety testing
BM Bennet, ID Pardo, BT Assaf, E Buza, SD Cramer, LTK Crawford, ...
Toxicologic Pathology 51 (5), 278-305, 2023
32023
Optimizing MRI-Guided Intra-Striatal AAV Dose Administration in Non-Human Primates
J Bu, B Elmer, B Assaf, C Dangler, M Goulet, C Mueller, S Ramachandran
MOLECULAR THERAPY 30 (4), 128-128, 2022
2022
Development of an AAV-Based microRNA Gene Therapy for Myotonic Dystrophy Type 1 (DM1)
NR Kollu, W Fan, J Sullivan, S Cao, J Cao, R Jackson, S Nass, B Nambiar, ...
MOLECULAR THERAPY 30 (4), 498-498, 2022
2022
New Insights into the Toxicity of AAV-Mediated Overexpression of Frataxin
C Huichalaf, TL Perfitt, A Kuperman, R Gooch, RC Kovi, K Brenneman, ...
MOLECULAR THERAPY 30 (4), 365-365, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–20